Collaboration Agreement between the Paul-Ehrlich-Institut and the Mexican Regulatory Authority COFEPRIS
On Tuesday, 11 October 2016, the Paul-Ehrlich-Institut and the Mexican regulatory authority COFEPRIS have entered into an agreement for future collaboration. The agreement between the two authorities was signed by Professor Klaus Cichutek, President of the PEI in Germany, and Julio Sánchez y Tépoz, Federal Commissioner for the Protection from Sanitary Risks at the Ministry of Health of the United Mexican States, during a summit meeting of the ICMRA at Interlaken, Switzerland.
Paediatric Committee of the European Medicines Agency (EMA) re-elects Dr Dirk Mentzer as its chair
After three years of successful work as chair of this important European committee, which has proved itself in a steady increase in marketing authorisations for paediatric medicines, Dr Dirk Mentzer, paediatrician and head of Unit Pharmacovigilance I of the Paul-Ehrlich-Institut, was re-elected as chair of the committee.
Zika virus reference material, prepared by PEI on behalf of the WHO, is available for advance distribution
As of Monday 25 July 2016, the WHO reference material for Zika virus RNA can be obtained from the PEI. It is expected to be endorsed in October 2016 at the Annual Meeting of the WHO Expert Committee on Biological Standardization (ECBS). In the meantime, the candidate reference material is available in advance in agreement with the WHO due to the ongoing Zika virus public health emergency.